United States Fitness Equipment Market Size & Outlook, 2026-2034
United States Fitness Equipment Market Insights
- Reed Intelligence analysis indicates that the United States Fitness Equipment Market size, valued at USD 3877.89 Million in 2025, is expected to expand to USD 6656.11 Million by 2034.
- The United States market is forecasted to expand at a CAGR of 6.21% spanning 2026–2034.
- Non-steroidal Anti-inflammatory Drugs (NSAIDS) held the leading position among By Drug segments in 2025, based on market size.
- Veterinary Antifungal Drugs is projected to post the fastest growth rate, sustaining its position as the most attractive By Drug segment during the forecast horizon.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- United States contributed 21.46% to the global Fitness Equipment Market size in 2025.
- By 2034, United States is forecasted to remain the largest global market for Fitness Equipment Market.
- In North America, United States is projected to capture the leading share of market size by 2034.
- Among North America markets, United States is expected to post the fastest growth, reaching USD 6669.38 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 3877.89 Million |
| Market Size In 2034 | USD 6656.11 Million |
| Largest segment | Non-steroidal Anti-inflammatory Drugs (NSAIDS) |
| Units | Revenue in USD Million |
| CAGR | 6.21% (2026-2034) |
| Segmnetation Covered | |
| By Drug |
|
| By Animal Type |
|
| By End User |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States Fitness Equipment Market By Drug 2026-2034 (USD Million)
| By Drug | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-steroidal Anti-inflammatory Drugs (NSAIDS) | XX.x | XX.x | XX.x | 1831.53 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Antibiotics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Veterinary Antifungal Drugs | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United States Fitness Equipment Market By Animal Type 2026-2034 (USD Million)
| By Animal Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Large Animals | XX.x | XX.x | XX.x | 2487.67 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Small Animals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United States Fitness Equipment Market By End User 2026-2034 (USD Million)
| By End User | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veterinary Hospitals | XX.x | XX.x | XX.x | 2505.51 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Veterinary Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.